hit counter
Viveve Medical, Inc. (VIVE) Stock News Sentiment & Price - Sentifly
VIVE - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Viveve Medical, Inc. (VIVE)

USA
Medical Appliances & Equipment
NASDAQ
VIVE Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
VIVE Latest news
Seeking Alpha
Neutral
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
2021-11-11 20:45

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript

Accesswire
Neutral
Viveve Reports Third Quarter 2021 Financial Results and Provides Corporate Update
2021-11-11 16:02

Total revenue of $1.6M reported for Q3 Pivotal SUI PURSUIT trial enrollment nears completion - randomizations on-track for completion in Q4 ENGLEWOOD, CO / ACCESSWIRE / November 11, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today reported financial results for the quarter ended September 30, 2021, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today. The Company's 10-Q documents will be filed on Friday, November 12, 2021, when the U.S. Securities and Exchange Commission reopens following the Veterans Day holiday.

Accesswire
Neutral
Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update
2021-11-02 08:28

ENGLEWOOD, CO / ACCESSWIRE / November 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its third quarter 2021 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 11, 2021. The Company will hold a conference call and webcast at 5:00 PM ET the same day.

Accesswire
Neutral
Viveve Announces Issuance of New Device and Methods Patent in U.S
2021-10-28 08:28

Issuance further expands and strengthens Company's intellectual property portfolio ENGLEWOOD, CO / ACCESSWIRE / October 28, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and Trademark Office (USPTO) recently issued U.S. Patent No. 11,154,349.

Accesswire
Neutral
Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia
2021-09-23 08:28

Patent strengthens and expands Viveve's intellectual property portfolio for the treatment of stress urinary incontinence ENGLEWOOD, CO / ACCESSWIRE / September 23, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Australian Patent Office has issued Patent No. 2016324168 covering Viveve's unique method of treatment to address stress urinary incontinence (SUI) in women.

PennyStocks
Positive
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
2021-09-20 14:30

Biotech penny stocks are heating up right now, here's three to watch The post Are Biotech Penny Stocks Worth Buying? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Accesswire
Neutral
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
2021-09-07 08:28

ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 - 15, 2021.

Seeking Alpha
Neutral
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript
2021-08-12 20:50

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript

Accesswire
Neutral
Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update
2021-08-12 16:01

Total revenue of $1.7M reported for Q2 Reported sales of approximately 3,500 consumable treatment tips - a 42% unit increase quarter-over-quarter Pivotal SUI PURSUIT trial enrollment on-track for completion in early Q4 Potential long-term reimbursement pathway established with new Category III CPT® code ENGLEWOOD, CO / ACCESSWIRE / August 12, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today reported financial results for the quarter ended June 30, 2021, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today. "During the second quarter of 2021, Viveve continued its focus on advancing its stress urinary incontinence (SUI) clinical development program.

Accesswire
Neutral
Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Update
2021-08-05 08:28

ENGLEWOOD, CO / ACCESSWIRE / August 5, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its second quarter 2021 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 12, 2021. The Company will hold a conference call and webcast at 5:00 PM ET the same day.

Loading more news...